CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics ","$":{"href":"/biotech/rising-tide-scenario-why-other-big-pharmas-could-follow-lilly-psychedelics","hreflang":"en"}}]}

Positive
AI Analysis

Summary

Eli Lilly acquired AtaiBeckley for $2.8 billion upfront, marking a significant entry into the psychedelics space that industry experts believe will drive momentum in the sector.

Importance:7/10
Sentiment:
0.60
acquisitionpsychedelicsbig pharmastrategic expansion
Related Companies

Read the original article

Published by FierceBiotech on July 18, 2026 9:40 AM

Read Original